University of Texas Health Science Center at Houston
Mir-484 Functions As An Onco-Mir In Triple Negative Breast Cancer
Abstract
dc:description.abstract<p>Triple negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer (BC), with a poor prognosis with currently used therapies, and thus represents an unmet therapeutic challenge. Lack of molecular targets (i.e. ER, PR, HER2) and significant genetic heterogeneity are the major reasons contributing to early relapse and high mortality rates. Numerous studies have indicated that microRNAs (miRs) have an important role in BC progression, invasion, angiogenesis, and metastasis. We analyzed miRNA expression profiles of BC patient data bases and identified that miR-484 is highly upregulated in all subtypes of BC patients, with the highest expression in TNBC patients. miR-484 was found to be associated with significantly shorter patient survival, while inhibition of miR-484 in TNBC cells led to significant reduction of cell proliferation, motility and invasion, and induced cell cycle arrest and apoptosis. Furthermore, we found that miR-484 is inversely correlated with levels of <em>HOXA5</em> in patients’ tumors and demonstrated that miR-484 directly binds to the 3¢-untranslated region (3¢-UTR) of <em>HOXA5 </em>mRNA to suppress its expression. Moreover, HOXA5 over-expression recapitulated the effects of miR-484 inhibition. <em>In vivo</em> therapeutic targeting of miR-484 by systemic administration of anti-miR-484 nanoparticles significantly induced HOXA5 expression and suppressed tumor growth and progression in orthotopic xenograft mouse models of TNBC. Thus, our findings provide new insights about the oncogenic role of miR-484 and suggest that miR-484 represents a novel therapeutic target in TNBC.</p>
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Level thesis:degree_level
- Dissertation (PhD)
- Year dc:date.available
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kabil, Nashwa
- <p>0000-0002-5413-849X</p>
- Contributors dc:contributor
-
- Bulent Ozpolat M.D. Ph.D
- Gabriel Lopez-Berestein M.D.
- George A. Calin M.D. Ph.D
Subjects
dc:subject × 5Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.tmc.edu/utgsbs_dissertations/897
- OAI identifier oai:identifier
- oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1943